The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508

This publication has 10 references indexed in Scilit:

• Initial pharmacology and toxicology of intravenous desmethylmisonidazole
  International Journal of Radiation Oncology*Biology*Physics, 1982
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981
• Radiation therapy oncology group clinical trials with misonidazole
  Cancer, 1981
• Neurotoxicity with desmethylmisonidazole
  The British Journal of Radiology, 1981
• The Pharmacokinetics and Tumor and Neural Tissue Penetrating Properties of SR-2508 and SR-2555 in the Dog-Hydrophilic Radiosensitizers Potentially Less Toxic than Misonidazole
  Radiation Research, 1980
• A drug for improved radiosensitization in radiotherapy
  British Journal of Cancer, 1980
• Partition Coefficient as a Guide to the Development of Radiosensitizers Which Are Less Toxic Than Misonidazole
  Radiation Research, 1980
• Misonidazole—A drug for trial in radiotherapy and oncology
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1978
• Radiosensitization by Misonidazole (Ro 07-0582) The Importance of Timing and Tumor Concentration of Sensitizer
  Radiation Research, 1978